Bristol-Myers Squibb Company 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-05 5:26 pm Purchase |
2019-11-20 | 13G | Jounce Therapeutics, Inc. JNCE |
BRISTOL MYERS SQUIBB CO BMY |
3,456,463 7.600% |
3,456,463 (New Position) |
Filing |